The Gamma Variant, also known as P.1, is a strain of the SARS-CoV-2 virus that was first identified in Brazil in late 2020. It is classified as a variant of concern due to its mutations, which may affect transmissibility and vaccine effectiveness. This variant has been associated with increased spread and potential resistance to neutralization by antibodies. Public health officials continue to monitor the Gamma Variant to understand its impact on the ongoing COVID-19 pandemic and to inform vaccination strategies.